BIOMAT Database Logo BIOMAT Database Logo

Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma. 1971

W F Sample, and H R Gertner, and P B Chretien

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

W F Sample, and H R Gertner, and P B Chretien
Inhibition of phytohemagglutinin-induced lymphocyte transformation by globulins; lack of correlation with phytohemagglutinin precipitation by serum proteins.
March 1972, Journal of immunology (Baltimore, Md. : 1950),
W F Sample, and H R Gertner, and P B Chretien
Leukemic serum inhibition of phytohemagglutinin-induced transformation.
July 1974, Journal of immunology (Baltimore, Md. : 1950),
W F Sample, and H R Gertner, and P B Chretien
Lymphocyte transformation by phytohemagglutinin. 3. In vitro cytotoxicity.
August 1968, Canadian Medical Association journal,
W F Sample, and H R Gertner, and P B Chretien
Reduction of phytohemagglutinin-induced lymphocyte transformation in patients with measles.
March 1970, Pediatrics,
W F Sample, and H R Gertner, and P B Chretien
Reduction of phytohemagglutinin-induced lymphocyte transformation in patients with measles.
March 1970, Pediatrics,
W F Sample, and H R Gertner, and P B Chretien
Phytohemagglutinin-induced lymphocyte transformation in newly presenting patients with primary carcinoma of the lung.
July 1975, Cancer,
W F Sample, and H R Gertner, and P B Chretien
Inhibition of phytohemagglutinin-, periodate- and A23187-induced lymphocyte transformation by vinca alkaloids.
December 1979, Experimental cell research,
W F Sample, and H R Gertner, and P B Chretien
Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
December 1983, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
W F Sample, and H R Gertner, and P B Chretien
[Studies on the cellular immune response in patients with bladder carcinoma. III. Inhibition of phytohemagglutinin-induced lymphocytes transformation by serum from the patients with bladder carcinoma (author's transl)].
March 1978, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
W F Sample, and H R Gertner, and P B Chretien
Ultrastructure of lymphocytes from patients with paracoccidioidomycosis in the lymphocyte transformation test by phytohemagglutinin.
March 1986, Mycopathologia,
Copied contents to your clipboard!